2801 - 2850 of 9140 Results
Title
Year
-
OPENTitle: Putting participants and study partners FIRST when clinical trials end earlyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 12Start Page: 2736End Page: 2746Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12732Best OA location URL: https://doi.org/10.1002/alz.12732Citation Count: 12
-
OPENTitle: Use of an Online Portal to Facilitate Clinical Trial Recruitment: A Preliminary Analysis of Fox Trial FinderJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 5Issue #: 1Start Page: 55End Page: 66Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-140522Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd140522?id=journal-of-parkinsons-disease%2Fjpd140522Citation Count: 14
-
OPENTitle: Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scoresJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 201End Page: 201Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00967-4Best OA location URL: https://www.nature.com/articles/s41531-025-00967-4.pdfCitation Count: 5
- Baseline-dependency: How genotype and signaled delays influence amphetamine's effects on delay discounting2020RESTRICTEDTitle: Baseline-dependency: How genotype and signaled delays influence amphetamine's effects on delay discountingJournal Name: Pharmacology Biochemistry and BehaviorPublisher: Elsevier BVVol: 199Issue #:Start Page: 173070End Page: 173070Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pbb.2020.173070Citation Count: 10
-
OPENTitle: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s diseaseJournal Name: Journal of Biopharmaceutical StatisticsPublisher: Informa UK LimitedVol: 35Issue #: 5Start Page: 981End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/10543406.2023.2170400Best OA location URL: https://doi.org/10.1080/10543406.2023.2170400Citation Count: 8
- Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to Action2022OPENTitle: Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to ActionJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 4Start Page: 1359End Page: 1363Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223190Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223190?id=journal-of-parkinsons-disease%2Fjpd223190Citation Count: 15
-
OPENTitle: Beyond Alzheimer’s disease—translating biomarker insights across CNS diseasesJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 17Issue #: 823Start Page: eadr2511End Page: eadr2511Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adr2511Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC13162155/Citation Count: 2
- Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease Patient2017RESTRICTEDTitle: Addition of Filgrastim (Neupogen) for Clozapine Rechallenge in the Case of Parkinson Disease PatientJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 40Issue #: 5Start Page: 233End Page: 234Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000230Citation Count: 7
- Recruitment Strategies across the Spectrum of Neuronal Synuclein Disease2026RESTRICTEDTitle: Recruitment Strategies across the Spectrum of Neuronal Synuclein DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.78239Citation Count: 0
-
OPENTitle: Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral OrgansJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 11Start Page: e80705End Page: e80705Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0080705Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0080705&type=printableCitation Count: 187
-
OPENTitle: Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitorsJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 473Issue #: 17Start Page: 2671End Page: 2685Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20160557Best OA location URL: https://portlandpress.com/biochemj/article-pdf/473/17/2671/687564/bj4732671.pdfCitation Count: 182
-
OPENTitle: Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophilsJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 475Issue #: 1Start Page: 23End Page: 44Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20170803Best OA location URL: https://portlandpress.com/biochemj/article-pdf/475/1/23/694098/bcj-2017-0803.pdfCitation Count: 179
-
OPENTitle: Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in RodentsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 8Issue #: 2Start Page: 303End Page: 322Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-171248Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd171248?id=journal-of-parkinsons-disease%2Fjpd171248Citation Count: 308
- Crossroads in GDNF therapy for Parkinson's disease2006RESTRICTEDTitle: Crossroads in GDNF therapy for Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 21Issue #: 2Start Page: 136End Page: 141Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.20861Citation Count: 174
-
OPENTitle: Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinaseJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 475Issue #: 1Start Page: 1End Page: 22Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20170802Best OA location URL: https://portlandpress.com/biochemj/article-pdf/475/1/1/694077/bcj-2017-0802.pdfCitation Count: 166
- Which dyskinesia scale best detects treatment response?2013RESTRICTEDTitle: Which dyskinesia scale best detects treatment response?Journal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 341End Page: 346Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25321Citation Count: 89
-
OPENTitle: Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 10Issue #: 10Start Page: 898End Page: 908Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(11)70175-2Best OA location URL: http://www.thelancet.com/article/S1474442211701752/pdfCitation Count: 344
-
OPENTitle: The Parkinson's Disease Genome‐Wide Association Study Locus BrowserJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2056End Page: 2067Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28197Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2021-00254%22Citation Count: 104
-
OPENTitle: The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary resultsJournal Name: Journal of Translational MedicinePublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 348End Page: 348Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12967-015-0704-9Best OA location URL: https://translational-medicine.biomedcentral.com/counter/pdf/10.1186/s12967-015-0704-9Citation Count: 105
-
OPENTitle: Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson’s Disease Research: The Fox Insight Cohort ExperienceJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 665End Page: 675Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-191901Best OA location URL: https://escholarship.org/uc/item/1rb4t3mzCitation Count: 61
-
OPENTitle: Evaluating community health workers' attributes, roles, and pathways of action in immigrant communitiesJournal Name: Preventive MedicinePublisher: Elsevier BVVol: 103Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ypmed.2017.07.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6354577Citation Count: 60
-
OPENTitle: The Future of GDNF in Parkinson's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page: 593572End Page: 593572Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.593572Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.593572/pdfCitation Count: 50
-
OPENTitle: Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task ForceJournal Name: Value in HealthPublisher: Elsevier BVVol: 26Issue #: 4Start Page: 449End Page: 460Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jval.2022.12.006Best OA location URL: http://www.valueinhealthjournal.com/article/S1098301522047805/pdfCitation Count: 40
-
OPENTitle: Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In VivoJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 148Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/59758-vBest OA location URL: https://www.jove.com/pdf/59758/generation-alpha-synuclein-preformed-fibrils-from-monomers-useCitation Count: 47
- Synthesis of Densely Functionalized N-Alkenyl 2-Pyridones via Benzyne-Induced Ring Opening of Thiazolino-Fused 2-Pyridones2019RESTRICTEDTitle: Synthesis of Densely Functionalized N-Alkenyl 2-Pyridones via Benzyne-Induced Ring Opening of Thiazolino-Fused 2-PyridonesJournal Name: Organic LettersPublisher: American Chemical Society (ACS)Vol: 21Issue #: 17Start Page: 6946End Page: 6950Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.orglett.9b02549Citation Count: 15
-
OPENTitle: Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrinaJournal Name: Journal of Extracellular BiologyPublisher: WileyVol: 1Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/jex2.59Best OA location URL: https://doi.org/10.1002/jex2.59Citation Count: 183
-
OPENTitle: The nosology of tardive syndromesJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 389Issue #:Start Page: 10End Page: 16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2018.02.008Best OA location URL: https://escholarship.org/uc/item/71p8z8wkCitation Count: 79
-
OPENTitle: Characterization of extracellular vesicles and synthetic nanoparticles with four orthogonal single‐particle analysis platformsJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 10Issue #: 6Start Page: e12079End Page: e12079Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/jev2.12079Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jev2.12079Citation Count: 220
-
OPENTitle: Distinct subcellular localization of tau and alpha-synuclein in lewy body diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 14End Page: 14Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s40478-024-01913-wBest OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-024-01913-wCitation Count: 4
- Divalent metal ions control activity and inhibition of protein kinases2017RESTRICTEDTitle: Divalent metal ions control activity and inhibition of protein kinasesJournal Name: MetallomicsPublisher: Oxford University Press (OUP)Vol: 9Issue #: 11Start Page: 1576End Page: 1584Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1039/c7mt00204aCitation Count: 62
-
OPENTitle: Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 miceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 22End Page: 22Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0426-8Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0426-8Citation Count: 97
-
OPENTitle: Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s diseaseJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 357Issue #: 6357Start Page: 1255End Page: 1261Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.aam9080Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6021018Citation Count: 874
-
OPENTitle: Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortexJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 571End Page: 582Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.09.023Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4315751Citation Count: 92
-
OPENTitle: IntranasalNAP(davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α‐synucleinJournal Name: Pharmacology Research & PerspectivesPublisher: WileyVol: 2Issue #: 5Start Page: e00065End Page: e00065Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/prp2.65Best OA location URL: https://doi.org/10.1002/prp2.65Citation Count: 43
-
RESTRICTEDTitle: The melanoma‐linked “redhead” MC1R influences dopaminergic neuron survivalJournal Name: Annals of NeurologyPublisher: WileyVol: 81Issue #: 3Start Page: 395End Page: 406Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.24852Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6085083Citation Count: 54
- Depressive symptoms may increase the risk of the future development of freezing of gait in patients with Parkinson's disease: Findings from a 5-year prospective study2018RESTRICTEDTitle: Depressive symptoms may increase the risk of the future development of freezing of gait in patients with Parkinson's disease: Findings from a 5-year prospective studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 98End Page: 104Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.09.013Citation Count: 43
- Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases2016OPENTitle: Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPasesJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.12813Best OA location URL: https://doi.org/10.7554/elife.12813Citation Count: 1079
- Safety Study of Transcranial Static Magnetic Field Stimulation (tSMS) of the Human Cortex2014OPENTitle: Safety Study of Transcranial Static Magnetic Field Stimulation (tSMS) of the Human CortexJournal Name: Brain StimulationPublisher: Elsevier BVVol: 8Issue #: 3Start Page: 481End Page: 485Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2014.12.002Citation Count: 56
- HT SpaceM: A high-throughput and reproducible method for small-molecule single-cell metabolomics2025OPENTitle: HT SpaceM: A high-throughput and reproducible method for small-molecule single-cell metabolomicsJournal Name: CellPublisher: Elsevier BVVol: 188Issue #: 21Start Page: 6028End Page: 6043.e11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.cell.2025.08.015Best OA location URL: https://doi.org/10.1016/j.cell.2025.08.015Citation Count: 20
-
OPENTitle: Advances in the genetics and pathology of Lewy body dementiaJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 24Issue #: 12Start Page: 1026End Page: 1037Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(25)00363-1Best OA location URL: https://hdl.handle.net/2123/34700Citation Count: 5
-
RESTRICTEDTitle: High complement levels in astrocyte‐derived exosomes of Alzheimer diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 83Issue #: 3Start Page: 544End Page: 552Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.25172Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5867263Citation Count: 387
-
OPENTitle: Prolonged Maturation Culture Favors a Reduction in the Tumorigenicity and the Dopaminergic Function of Human ESC‐Derived Neural Cells in a Primate Model of Parkinson's DiseaseJournal Name: STEM CELLSPublisher: Oxford University Press (OUP)Vol: 30Issue #: 5Start Page: 935End Page: 945Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/stem.1060Best OA location URL: https://academic.oup.com/stmcls/article-pdf/30/5/935/40773621/stmcls_30_5_935.pdfCitation Count: 169
-
OPENTitle: Striatal shape abnormalities as novel neurodevelopmental endophenotypes in schizophrenia: A longitudinal studyJournal Name: Human Brain MappingPublisher: WileyVol: 36Issue #: 4Start Page: 1458End Page: 1469Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.22715Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.22715?download=trueCitation Count: 67
- Autonomic nervous system and gastrointestinal manifestations with an emphasis on gastric dysfunction2026RESTRICTEDTitle: Autonomic nervous system and gastrointestinal manifestations with an emphasis on gastric dysfunctionJournal Name: Autonomic NeurosciencePublisher: Elsevier BVVol: 268Issue #:Start Page: 103474End Page: 103474Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.autneu.2026.103474Citation Count: 0
- Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice2018RESTRICTEDTitle: Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in miceJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 465Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aah4066Citation Count: 894
- Crowdsourcing and machine learning contests in Parkinson's disease research - when do they work?2026OPENTitle: Crowdsourcing and machine learning contests in Parkinson's disease research - when do they work?Journal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol:Issue #:Start Page: 1877718X261452116End Page: 1877718X261452116Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/1877718x261452116Best OA location URL: https://doi.org/10.1177/1877718x261452116Citation Count: 0
- TDP-43–Associated Neurodegenerative Disease Conceptualization and Integrated Staging2026RESTRICTEDTitle: TDP-43–Associated Neurodegenerative Disease Conceptualization and Integrated StagingJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2026.2812Citation Count: 0
- Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies2026OPENTitle: Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathiesJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 16Issue #: 6Start Page: 1877718X261463936End Page: 1877718X261463936Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x261463936Citation Count: 0
-
OPENTitle: Longitudinal characterization of clinical, developmental, and behavioral phenotypes in 101 children and adults with FOXG1 syndromeJournal Name: Journal of Neurodevelopmental DisordersPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page: 64End Page: 64Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s11689-025-09653-1Best OA location URL: https://jneurodevdisorders.biomedcentral.com/counter/pdf/10.1186/s11689-025-09653-1Citation Count: 3
- Oxidative Damage in Parkinson's Disease2005RESTRICTEDTitle: Oxidative Damage in Parkinson's DiseaseJournal Name: Antioxidants & Redox SignalingPublisher: SAGE PublicationsVol: 7Issue #: 5-6Start Page: 627End Page: 629Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1089/ars.2005.7.627Citation Count: 27